Ligand Pharma (LGND) to resume trading at 9:45AM after FDA approval
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Join SI Premium – FREE
Ligand Pharmaceuticals (Nasdaq: LGND) to resume trading at 9:45AM ET following FDA approval for PROMACTA
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- FDA grants accelerated approval to Ultragenyx gene therapy for GSDIa
- FDA grants fast track status to Rein Therapeutics drug for lung fibrosis
Create E-mail Alert Related Categories
FDA, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
